Showing results (151-160 of 521) with videos related to
Sort By:
Pageof 53
JACC. Heart Failure|January 4, 2023
Prediction of Left Ventricular Ejection Fraction Change Following Treatment With Sacubitril/ValsartanReza Mohebi, Yuxi Liu, G Michael Felker, et al.Physiological Genomics|March 16, 2019
Salt-sensitive transcriptome of isolated kidney distal tubule cellsElizabeth A Swanson, Jonathan W Nelson, Sophia Jeng, et al.Hypertension (Dallas, Tex. : 1979)|March 11, 2024
Potassium-Switch Signaling Pathway Dictates Acute Blood Pressure Response to Dietary PotassiumPaul A Welling, Robert Little, Lama Al-Qusairi, et al.ESC Heart Failure|August 26, 2023
Importance of the 'area under the curve' from serial NT-proBNP measurements during treatment with sacubitril/valsartanReza Mohebi, Yuxi Liu, Javed Butler, et al.Journal of the American College of Cardiology|October 13, 2022
Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection FractionReza Mohebi, Yuxi Liu, Ileana L Piña, et al.Circulation|July 6, 2006
Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantationBrian Lima, Keshava Rajagopal, Rebecca P Petersen, et al.Journal of the American Heart Association|April 14, 2018
Machine Learning Methods Improve Prognostication, Identify Clinically Distinct Phenotypes, and Detect Heterogeneity in Response to Therapy in a Large Cohort of Heart Failure PatientsTariq Ahmad, Lars H Lund, Pooja Rao, et al.Circulation. Heart Failure|July 12, 2011
Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claimsRobb D Kociol, John R Horton, Gregg C Fonarow, et al.JACC. Heart Failure|March 7, 2023
Medication-Attributable Adverse Events in Heart Failure TrialsJosephine Harrington, Gregg C Fonarow, Muhammad Shahzeb Khan, et al.American Heart Journal|September 29, 2009
N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) studyG Michael Felker, David Whellan, William E Kraus, et al.Pageof 53